Literature DB >> 11512048

Effects of high-affinity GABAB receptor antagonists on active and passive avoidance responding in rodents with gamma-hydroxybutyrolactone-induced absence syndrome.

D P Getova1, N G Bowery.   

Abstract

RATIONALE: Absence seizures in man are behaviourally manifested as arrest and mild jerks mainly of facial muscles, associated in the electroencephalogram with synchronous spike and wave discharges. Gamma-hydroxybutyrolactone (GHBL) administration is currently used as an experimental model of absence seizures in rats and mice.
OBJECTIVE: The aim of the present study was to examine the effects of three potent gamma-aminobutyric acid (GABA)B receptor antagonists CGP55845A, CGP62349 and CGP71982 (0.01 mg/kg) on the development of GHBL-induced absence epilepsy and in learning paradigms of active and passive avoidance tests in GHBL-treated mice and rats.
METHODS: After 4 weeks of development of the absence syndrome, active and passive avoidance tests with negative reinforcement were performed. In both animal species, the absence syndrome was observed after 3 weeks of treatment in the saline group.
RESULTS: The GABAB receptor antagonists CGP55845A and CGP62349 appeared to suppress the development of the absence syndrome to a greater degree in mice than in rats. CGP71982 suppressed it later than the other two antagonists (fifth week). In an active avoidance test in GHBL-treated mice, the GABAB antagonists had different effects - CGP62349 improved learning and memory retention to a greater extent than CGP55845A, whilst CGP71982 had no influence on it. In a passive avoidance test in GHBL-treated mice, the GABAB antagonists also had different effects - CGP71982 improved both learning and memory retrieval, whereas CGP55845A and CGP62349 had no effect. In the active avoidance test in GHBL-treated rats, the GABAB antagonist CGP55845A improved learning, whereas the other two, CGP62349 and CGP71982, had no effect. In the passive avoidance test the GHBL-treated rats showed an improvement in short memory retrieval. CGP55845A and CGP71982 improved this further, whilst CGP62349 had no effect.
CONCLUSIONS: GHBL appeared to influence mice and rats in a different manner - rats learned the active avoidance task better than the GHBL-treated mice. The present study confirms previous data that GABAB antagonists suppress absence behaviour.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11512048     DOI: 10.1007/s002130100766

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Contribution of GABA receptors to extinction of memory traces in normal conditions and in a depression-like state.

Authors:  N I Dubrovina; D R Zinov'ev
Journal:  Neurosci Behav Physiol       Date:  2008-09-18

2.  Age-related changes in rostral basal forebrain cholinergic and GABAergic projection neurons: relationship with spatial impairment.

Authors:  Cristina Bañuelos; Candi L LaSarge; Joseph A McQuail; John J Hartman; Ryan J Gilbert; Brandi K Ormerod; Jennifer L Bizon
Journal:  Neurobiol Aging       Date:  2012-07-18       Impact factor: 4.673

Review 3.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

4.  Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Mehrdad Faizi; Lucia F Jacobs; Khin Htun; Mehrdad Shamloo; William C Mobley
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

5.  Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice.

Authors:  Martin Gassmann; Hamdy Shaban; Réjan Vigot; Gilles Sansig; Corinne Haller; Samuel Barbieri; Yann Humeau; Valérie Schuler; Matthias Müller; Bernd Kinzel; Klaus Klebs; Markus Schmutz; Wolfgang Froestl; Jakob Heid; Peter H Kelly; Clive Gentry; Anne-Lise Jaton; Herman Van der Putten; Cédric Mombereau; Lucas Lecourtier; Johannes Mosbacher; John F Cryan; Jean-Marc Fritschy; Andreas Lüthi; Klemens Kaupmann; Bernhard Bettler
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

6.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07

7.  Blockade of GABA(B) receptors completely reverses age-related learning impairment.

Authors:  C L Lasarge; C Bañuelos; J D Mayse; J L Bizon
Journal:  Neuroscience       Date:  2009-08-31       Impact factor: 3.590

Review 8.  GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment.

Authors:  Yilan Xu; Manna Zhao; Yuying Han; Heng Zhang
Journal:  Front Neurosci       Date:  2020-06-30       Impact factor: 4.677

Review 9.  Implications of GABAergic Neurotransmission in Alzheimer's Disease.

Authors:  Yanfang Li; Hao Sun; Zhicai Chen; Huaxi Xu; Guojun Bu; Hui Zheng
Journal:  Front Aging Neurosci       Date:  2016-02-23       Impact factor: 5.750

Review 10.  GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease.

Authors:  Joan Jiménez-Balado; Teal S Eich
Journal:  Semin Cell Dev Biol       Date:  2021-02-09       Impact factor: 7.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.